Ong, Ariel Yuhan
Struyven, Robbert R.
Denniston, Alastair K.
Merle, David A.
Engelmann, Justin
Kim, Hyunmin
Zhou, Yukun
Keane, Pearse A.
Lains, Ines
Article History
Received: 8 November 2025
Accepted: 11 February 2026
First Online: 25 February 2026
Competing interests
: P.A.K. is a cofounder of Cascader Ltd. and has acted as a consultant for Retina Consultants of America, Roche, Boehringer-Ingelheim, and Bitfount and is an equity owner in Big Picture Medical. He has received speaker fees from Zeiss, Thea, Apellis, and Roche. He has received travel support from Bayer and Roche. He has attended advisory boards for Topcon, Bayer, Boehringer-Ingelheim, and Roche. I.L. has attended advisory boards for EyePoint and 4D Molecular Therapeutics, Inc. The remaining authors do not have any conflicts of interest to declare.